Drug Resistance and Predicted Virologic Responses to Human Immunodeficiency Virus Type 1 Protease Inhibitor Therapy
Year: 2000
Type: article
DOI: 10.1086/315782
Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2127840648
